CP-609754(OSI754)

Modify Date: 2024-01-02 23:10:40

CP-609754(OSI754) Structure
CP-609754(OSI754) structure
Common Name CP-609754(OSI754)
CAS Number 1190094-64-4 Molecular Weight 479.95700
Density 1.23±0.1 g/cm3 Boiling Point 702.4±60.0 °C
Molecular Formula C29H22ClN3O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of CP-609754(OSI754)


CP-609754 (LNK-754) is a potent and reversible farnesyltransferase inhibitor with potential anticancer activity.The IC50 for inhibiting farnesylation of recombinant human H-Ras is 0.57 ng/mL and recombinant K-Ras is 46 ng/mL[1].

 Names

Name 6-[(R)-(4-chlorophenyl)-hydroxy-(3-methylimidazol-4-yl)methyl]-4-(3-ethynylphenyl)-1-methylquinolin-2-one
Synonym More Synonyms

 CP-609754(OSI754) Biological Activity

Description CP-609754 (LNK-754) is a potent and reversible farnesyltransferase inhibitor with potential anticancer activity.The IC50 for inhibiting farnesylation of recombinant human H-Ras is 0.57 ng/mL and recombinant K-Ras is 46 ng/mL[1].
Related Catalog
In Vitro CP-609754 (CP-609,754) is a reversible inhibitor of farnesyltransferase with a slow on/off rate. CP-609,754 inhibits farnesylation (IC50=1.72 ng/mL) of mutant H-Ras in 3T3 H-ras (61L)-transfected cell lines with SDS-PAGE analysis of [35S]methionine-labeled material[1]. CP-609754 is competitive for the prenyl acceptor (H-Ras protein) and noncompetitive for the prenyl donor farnesyl PPI. CP-609754 interacts with the farnesyltransferase-farnesyl PPI complex and competes for the binding of the Ras protein. CP-609754 selectively inhibits farnesylation of both H- and K-Ras proteins in 3T3 transfectants[1].
In Vivo CP-609754 (CP-609,754) has antitumor activity against 3T3 H-ras (61L) tumors in vivo[1]. With twice daily oral dosing of CP-609754, tumor regression is achieved with a dose of 100 mg/kg; the ED50 for tumor growth inhibition is 28 mg/kg[1]. With continuous i.p. infusion of CP-609754, tumor growth is inhibited by >50%, and tumor farnesyltransferase activity inhibited by >30% in mice in which the plasma concentration of CP-609754 is maintained above 118 ng/mL[1].
References

[1]. Stacy L Moulder, et al. A phase I open label study of the farnesyltransferase inhibitor CP-609,754 in patients with advanced malignant tumors. Clin Cancer Res. 2004 Nov 1;10(21):7127-35.

 Chemical & Physical Properties

Density 1.23±0.1 g/cm3
Boiling Point 702.4±60.0 °C
Molecular Formula C29H22ClN3O2
Molecular Weight 479.95700
Exact Mass 479.14000
PSA 60.05000
LogP 4.85790

 Synonyms

unii-l0s47w9gpy
CP-609754(OSI754)